SCHEMBL23809451

SCHEMBL23809451

Cc1cc(C)c2c(c1)c(C(=O)O)cn2C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.41
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ CSNK2A1 P68400 1/20 0.38
▸ NOTUM Q6P988 2/20 0.37
▸ POLB P06746 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ THRB P10828 1/20 0.35
▸ TPMT P51580 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ APEX1 P27695 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ RCE1 Q9Y256 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ METAP2 P50579 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MTNR1A P48039 1/20 0.35
▸ MTNR1B P49286 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19657311 0.82 BRD4 (0.48) KDM4EALDH1A1POLBTHRBGAA
SCHEMBL1094507 0.76 CDK2 (0.46) KDM4EALDH1A1MEN1KMT2APOLB
SCHEMBL23809426 0.75 POLB (0.41) KDM4EALDH1A1MEN1KMT2APOLB
SCHEMBL23809364 0.74 MTNR1A (0.43) ALDH1A1MEN1KMT2AMAPTMTNR1A
SCHEMBL12167181 0.74 KMT2A (0.56) KDM4EALDH1A1MEN1KMT2ACSNK2A1
SCHEMBL30622587 0.74 KMT2A (0.56) KDM4EALDH1A1MEN1KMT2ACSNK2A1
SCHEMBL26581622 0.73 MCL1 (0.39) KDM4EMEN1KMT2APOLBMTNR1A
SCHEMBL26581558 0.72 HRH3 (0.42) KDM4EALDH1A1KMT2APOLBMAPT
SCHEMBL12748781 0.72 AKR1C3 (0.49) KDM4EMEN1KMT2AGAAMETAP2
SCHEMBL26581168 0.71 TPMT (0.42) KDM4EALDH1A1MEN1KMT2ANOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 — — US disclosed
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 — — US disclosed
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 KDM4E 1156/4885ALDH1A1 2556/4885MEN1 3549/4885
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 KDM4E 1156/4885ALDH1A1 2556/4885MEN1 3549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback